Section 8.3: Referrals, Consultations, and Interprofessional Collaboration

Effective primary care delivery depends on the family nurse practitioner’s (FNP) ability to recognize the boundaries of their scope of practice, coordinate care across specialty boundaries, and engage in interprofessional collaboration. Knowing when to manage a condition independently, when to consult, and when to refer is essential for patient safety and is a core focus of the AANP exam.

Cardiovascular Referral Criteria

While FNPs manage the vast majority of cardiovascular diseases, specific clinical milestones necessitate referral to a cardiologist:

• Resistant Hypertension: Defined as blood pressure that remains above target (<130/80 mmHg) despite the concurrent use of three antihypertensive chemical classes, one of which must be a diuretic, prescribed at optimal doses. It also includes patients whose blood pressure is controlled but requires four or more medications. Referral to a hypertension specialist or cardiologist is indicated to rule out secondary causes and optimize therapy. FNP preliminary workup includes screening for primary aldosteronism via plasma aldosterone concentration (PAC) and plasma renin activity (PRA) ratios, and ordering a renal artery duplex ultrasound.
• New-Onset Heart Failure: Any patient presenting with signs or symptoms of heart failure (e.g., bilateral peripheral edema, paroxysmal nocturnal dyspnea, orthopnea, S3 gallop) must be referred to cardiology. This ensures a baseline transthoracic echocardiogram to distinguish between HFrEF and HFpEF. Cardiology collaboration is essential to optimize Guideline-Directed Medical Therapy (GDMT), which relies on four pharmacological pillars: beta-blockers (e.g., carvedilol), RAAS inhibitors (preferably an ARNI like sacubitril/valsartan), SGLT2 inhibitors, and mineralocorticoid receptor antagonists.
• Valvular Heart Disease: Any diastolic murmur, a systolic murmur graded 3/6 or louder, or any murmur accompanied by cardiovascular symptoms (such as exertional dyspnea, chest pain, presyncope, or syncope) requires a cardiology referral and diagnostic echocardiography. Additionally, pregnant patients with pre-existing valvular disease or new-onset murmurs must be referred immediately due to the physiological volume changes of pregnancy that can precipitate acute heart failure.

Endocrine Referral Parameters

Complex endocrine disorders often require co-management with an endocrinologist:

• Type 1 vs. Type 2 Diabetes: All patients with newly diagnosed Type 1 diabetes must be referred to endocrinology for intensive insulin management, continuous glucose monitor (CGM) training, and insulin pump coordination. FNPs must maintain a high index of suspicion for latent autoimmune diabetes in adults (LADA), which presents similarly to type 2 diabetes but requires early insulin therapy and specialty referral. For patients with Type 2 diabetes, referral is indicated if glycemic targets are not met despite triple oral/injectable therapy, if there is a rapid decline in renal function (eGFR <30 mL/min/1.73m2), or if they develop progressive microvascular complications (e.g., proliferative diabetic retinopathy or autonomic neuropathy).
• Secondary Hypertension: If clinical findings suggest a secondary cause—such as primary aldosteronism (refractory hypokalemia), pheochromocytoma (paroxysmal hypertension, headaches, diaphoresis, palpitations), or renal artery stenosis (systolic-diastolic abdominal bruit)—the FNP should initiate screening and refer to endocrinology or nephrology.
• Thyroid Nodules: Any palpable thyroid nodule or nodule discovered incidentally on imaging that measures >1 cm in diameter, or any nodule with suspicious sonographic characteristics (e.g., microcalcifications, irregular margins, hypoechoic appearance) regardless of size, warrants referral to an endocrinologist or general surgeon for a fine-needle aspiration (FNA) biopsy. Post-biopsy management is guided by the Bethesda classification system.

Pulmonary Referral Parameters

Refractory pulmonary diseases require pulmonologist intervention to prevent acute respiratory failure:

• Severe or Uncontrolled Asthma: Patients who remain uncontrolled (frequent daytime symptoms, nighttime awakenings, or limitation of activity) at GINA Step 4 or 5 therapy, or those who require two or more courses of oral systemic corticosteroids per year despite demonstrated adherence to inhaled therapies and correct inhaler technique, must be referred to pulmonology for advanced phenotypic assessment (e.g., checking IgE or eosinophil levels) and potential biologic therapy.
• Advanced COPD: Referral to a pulmonologist is recommended for patients with an FEV1 <50% of predicted, those experiencing two or more moderate exacerbations or one hospitalization annually despite triple therapy, patients requiring evaluation for long-term oxygen therapy (resting SaO2 <88% or PaO2 <55 mmHg), and candidates for pulmonary rehabilitation. FNPs utilize spirometry and pulmonary function tests (PFTs) to confirm severity and rule out asthma-COPD overlap syndrome.

Interprofessional Collaboration and Care Coordination

Managing chronic, multi-system diseases requires an interdisciplinary team. The FNP coordinates this team to provide comprehensive, patient-centered care:

• Team Roles: The FNP collaborates with Physical Therapists (PT) to address gait, balance, and assistive device needs; Occupational Therapists (OT) to assess home safety and activities of daily living (ADLs); Speech-Language Pathologists (SLP) to evaluate dysphagia and cognitive-communication disorders; Registered Dietitians to optimize nutrition in chronic renal failure or severe diabetes; Certified Diabetes Educators (CDE) to provide diabetes self-management education; and Clinical Pharmacists to assist with complex medication titration and polypharmacy reconciliation.
• Transitions of Care: The period immediately following hospital discharge is high-risk. Evidence-based care transition models (such as the Transitional Care Model) reduce readmission rates. The FNP should ensure a follow-up telephone call is made to the patient within 48 to 72 hours of discharge to assess symptoms and medication access, followed by an in-person primary care clinic visit within 7 to 14 days. During this visit, a formal medication reconciliation must be performed by identifying the 'three Cs': comparison of pre-admission and current regimens, checking for drug-drug interactions or therapeutic duplications, and correction of discrepancies. Special attention must be paid to high-risk medications, such as anticoagulants, insulin, and antiplatelets, which are responsible for a disproportionate number of post-discharge adverse events.